CUSTOM ANTIBODY SERVICE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 to 2030)
CUSTOM ANTIBODY SERVICE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 to 2030)
Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
- Published In: 28 Sep, 2022
- Code: CMI5254
- Pages: 227
- Formats: Excel and PDF
- Industry: Pharmaceutical
Antibodies are produced by the immune system in response to invading pathogens. The invading bacteria, virus, or other foreign molecules are collectively called as antigens. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. Antibodies are formed by B-cells of the immune system. When an antibody is needed against a specific antigen, but it isn’t available from a supplier, it is possible to have antibodies made via custom antibody production. These antibodies are of two types depending on how they are generated and harvested: polyclonal or monoclonal. Polyclonal antibodies are capable of recognizing multiple sites on an antigen. They are derived from different B cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. There are six steps to polyclonal antibody production:
- Peptide design
- Peptide synthesis
- Animal immunization
- Serum collection
- Titer analysis
- Final antibody purification
Thus, key market player provide services in all or some of these above mentioned steps.
Market Dynamics
Increasing launches of new customized antibody services by key market players and advantages of using antibodies for various applications is expected to provide lucrative growth to Global Custom Antibody Service Market for the forecast period. In addition, increase in the funding by various organizations in R&D is expected to drive the growth of global custom antibody service market over the forecast period. For instance, according to an article published by R&D world on April 20, 2022, the U.S. industrial organizations are expected to collectively invest US$ 447 billion in R&D of health care. Moreover, the U.S. federal government is expected to invest US$ 181.4 billion in R&D of health care in 2022.
Key features of the study:
- This report provides an in-depth analysis of the global custom antibody service market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted By key players
- It profiles key players in the global custom antibody service market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Genscript, Abcam plc., Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., BioLegend, Inc., ROCKLAND IMMUNOCHEMICALS, INC., ProMab, Innovagen AB, ProteoGenix, Bio-Techne., Creative Diagnostics., Sino Biological, Inc., RayBiotech Life, Inc., Abbiotec, Inc., ProSci Incorporated, Capralogics, Inc., Boster Biological Technology.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global custom antibody service market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Custom Antibody Service Market
Detailed Segmentation:
- Global Custom Antibody Service market, By Service Type:
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- Global Custom Antibody Service market, By Product Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Global Custom Antibody Service market, By Source:
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- Global Custom Antibody Service market, By Application:
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- Global Custom Antibody Service market, By End Users:
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- Global Custom Antibody Service Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Country/Region
- North America
- Company Profiles
- Thermo Fisher Scientific, Inc.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genscript
- Abcam plc.
- Cell Signaling Technology, Inc
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- BioLegend, Inc.
- ROCKLAND IMMUNOCHEMICALS, INC.
- ProMab
- Innovagen AB
- ProteoGenix
- Bio-Techne.
- Creative Diagnostics.
- Sino Biological, Inc.
- RayBiotech Life, Inc.
- Abbiotec, Inc.
- ProSci Incorporated
- Capralogics, Inc.
- Boster Biological Technology
- Thermo Fisher Scientific, Inc.*
“*” marked represents similar segmentation in other categories in the respective section.
Detailed Segmentation:
Global Custom Antibody Service market, By Service Type:
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
Global Custom Antibody Service market, By Product Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
Global Custom Antibody Service market, By Source:
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
Global Custom Antibody Service market, By Application:
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
Global Custom Antibody Service market, By End Users:
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
Global Custom Antibody Service Market, By Region:
- North America
- By Service Type
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- By Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Source
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- By Application
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- By End Users
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- By Country
- U.S.
- Canada
- By Service Type
- Latin America
- By Service Type
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- By Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Source
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- By Application
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- By End Users
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Service Type
- Europe
- By Service Type
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- By Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Source
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- By Application
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- By End Users
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Service Type
- Asia Pacific
- By Service Type
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- By Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Source
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- By Application
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- By End Users
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Service Type
- Middle East
- By Service Type
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- By Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Source
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- By Application
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- By End Users
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- By Country
- GCC
- Israel
- Rest of Middle East
- By Service Type
- Africa
- By Service Type
- Antibody Development
- Antibody Production
- Downstream Antibody Services
- Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)
- By Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Source
- Rabbit
- Chicken
- Guinea pig
- Goat
- Mouse
- Others (Rat and Others)
- By Application
- Oncology
- Infectious diseases
- Immunology
- Neurobiology
- Stem cells
- Other (Cardiovascular Disease and Others)
- By End Users
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- Contract research organizations
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Service Type
- North America
Company Profiles
- Thermo Fisher Scientific, Inc.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genscript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cell Signaling Technology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioLegend, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ROCKLAND IMMUNOCHEMICALS, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ProMab
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Innovagen AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ProteoGenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Techne.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Diagnostics.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RayBiotech Life, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbiotec, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ProSci Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Capralogics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boster Biological Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific, Inc.*
-
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.
